Inventor · disambiguated record
Dennis James Hurley
Also filed as: HURLEY DENNIS · HURLEY DENNIS J · HURLEY DENNIS JAMES
43 granted patents·27 pending applications·1,030 citations·filing 2004–2025
98Inventor score
Top patents by PatentIndex Score
70 records- 0198US8999976B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2013·Granted Apr 7, 2015·105 cites·22 claims
- 0298US8785640B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2013·Granted Jul 22, 2014·72 cites·35 claims
- 0398US8598205B2Modulators of cystic fibrosis transmembrane conductance regulatorBINCH HAYLEY·Filed 2012·Granted Dec 3, 2013·77 cites·22 claims
- 0498US8513282B2Modulators of cystic fibrosis transmembrane conductance regulatorBINCH HAYLEY·Filed 2009·Granted Aug 20, 2013·84 cites·11 claims
- 0597US8884018B2Process for preparing modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2014·Granted Nov 11, 2014·62 cites·7 claims
- 0697US8754222B2Process for preparing modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2012·Granted Jun 17, 2014·66 cites·14 claims
- 0797US8614327B2Modulators of ATP-binding cassette transportersVERTEX PHARMA·Filed 2012·Granted Dec 24, 2013·78 cites·9 claims
- 0897US8410112B2Compounds useful as inhibitors of ATR kinaseCHARRIER JEAN-DAMIEN·Filed 2011·Granted Apr 2, 2013·56 cites·71 claims
- 0997US8367660B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2009·Granted Feb 5, 2013·85 cites·17 claims
- 1097US8344147B2Process for preparing modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2010·Granted Jan 1, 2013·90 cites·24 claims
- 1196US8633189B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2012·Granted Jan 21, 2014·68 cites·24 claims
- 1295US11834441B2Substituted tetrahydrofurans as modulators of sodium channelsVERTEX PHARMA·Filed 2020·Granted Dec 5, 2023·4 cites·62 claims
- 1395US11827627B2N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channelsVERTEX PHARMA·Filed 2022·Granted Nov 28, 2023·3 cites·37 claims
- 1495US10647661B2Carboxamides as modulators of sodium channelsVERTEX PHARMA·Filed 2018·Granted May 12, 2020·15 cites·106 claims
- 1594US11919887B2Substituted tetrahydrofurans as modulators of sodium channelsVERTEX PHARMA·Filed 2022·Granted Mar 5, 2024·2 cites·21 claims
- 1694US8802700B2Modulators of ATP-Binding Cassette transportersSHETH URVI·Filed 2012·Granted Aug 12, 2014·74 cites·5 claims
- 1794US8283354B2Quinazolines useful as modulators of ion channelsWILSON DEAN·Filed 2005·Granted Oct 9, 2012·22 cites·39 claims
- 1893US12247021B2Substituted tetrahydrofurans as modulators of sodium channelsVERTEX PHARMA·Filed 2023·Granted Mar 11, 2025·1 cites·24 claims
- 1993US11603351B2Carboxamides as modulators of sodium channelsVERTEX PHARMA·Filed 2020·Granted Mar 14, 2023·3 cites·27 claims
- 2091US12281057B2Carboxamides as modulators of sodium channelsVERTEX PHARMA·Filed 2022·Granted Apr 22, 2025·1 cites·15 claims
- 2191US11884672B2Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2020·Granted Jan 30, 2024·4 cites·11 claims
- 2290US7858635B2Spiro compounds as modulators of muscarinic receptorsVERTEX PHARMA·Filed 2006·Granted Dec 28, 2010·24 cites·19 claims
- 2389US12331057B2Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2023·Granted Jun 17, 2025·1 cites·11 claims
- 2487US8497295B2Spiroindoline modulators of muscarinic receptorsMAKINGS LEWIS R·Filed 2012·Granted Jul 30, 2013·10 cites·22 claims
- 2586US7928107B2Quinazolines useful as modulators of ion channelsVERTEX PHARMA·Filed 2006·Granted Apr 19, 2011·9 cites·5 claims
- 2685US2025197381A1Substituted tetrahydrofurans as modulators of sodium channelsVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 2781US7696201B2Modulators of muscarinic receptorsVERTEX PHARMA·Filed 2007·Granted Apr 13, 2010·4 cites·37 claims
- 2880US12258333B2N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channelsVERTEX PHARMA·Filed 2023·Granted Mar 25, 2025·0 cites·22 claims
- 2979US11623924B2Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2019·Granted Apr 11, 2023·3 cites·15 claims
- 3076US7880007B2Bicyclic substituted phenyl piperidine modulators of muscarinic receptorsVERTEX PHARMA·Filed 2005·Granted Feb 1, 2011·3 cites·7 claims
- 3174US7786141B2Dihydrospiroindene modulators of muscarinic receptorsVERTEX PHARMA·Filed 2006·Granted Aug 31, 2010·1 cites·2 claims
- 3269US8263605B2Modulators of muscarinic receptorsMAKINGS LEWIS R·Filed 2007·Granted Sep 11, 2012·1 cites·18 claims
- 3369US2025353836A1N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channelsVERTEX PHARMA·Filed 2025·Application pending·0 cites
- 3468US2023265080A1Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 3562US2014303204A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2014·Application pending·0 cites
- 3662US2023382910A1Heteroaryl compounds for the treatment of painVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 3761US2014336393A1Process for preparing modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2014·Application pending·0 cites
- 3860US2025388541A1Heteroaryl compounds for the treatment of painVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 3960US2024294512A1Hydroxy and (halo)alkoxy substituted tetrahydrofurans as modulators of sodium channelsVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 4059US12503439B2Heteroaryl compounds for the treatment of painVERTEX PHARMA·Filed 2023·Granted Dec 23, 2025·0 cites·35 claims
- 4158US7465738B2Compounds useful as promoters of SMN2VERTEX PHARMA·Filed 2004·Granted Dec 16, 2008·2 cites·10 claims
- 4258US2024400544A1N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamide analogs as modulators of sodium channelsVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 4358US2013281476A1Modulators of Muscarinic ReceptorsVERTEX PHARMA·Filed 2013·Application pending·0 cites
- 4458US2024368135A1Substituted tetrahydrofuran-2-carboxamides as modulators of sodium channelsVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 4558US2025388543A1Heteroaryl compounds for the treatment of painVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 4658US2013158071A1Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2012·Application pending·0 cites
- 4757US2013131107A1Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2012·Application pending·0 cites
- 4857US2025213555A1Substituted tetrahydrofuran analogs as modulators of sodium channelsVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 4956US8367691B2Modulators of muscarinic receptorsVERTEX PHARMA·Filed 2010·Granted Feb 5, 2013·0 cites·5 claims
- 5055US9181273B2Morpholine-spirocyclic piperidine amides as modulators of ion channelsVERTEX PHARMA·Filed 2014·Granted Nov 10, 2015·0 cites·21 claims
Showing the top 50 of 70 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Dennis James Hurley files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →